Compare Guardant Health Inc. Common Stock (GH) vs Moody's Corporation (MCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Moody's Corporation — how do they compare? Guardant Health Inc. Common Stock trades at $167.65 (market cap $22.22B), while Moody's Corporation trades at $460 (market cap $79.44B). The key difference: Moody's Corporation is far larger — about 3.6× Guardant Health Inc. Common Stock's market cap, and Moody's Corporation pays a 0.9% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Moody's Corporation for 132 Days on average.
| GH | MCO | |
|---|---|---|
Market Cap | $22.22B | $79.44B |
Volume | 1,589,453 | 526,684 |
Sector | Health | Financials |
52-Week High | $187.22 | $539.61 |
52-Week Low | $61.73 | $412.23 |
Typical Hold Time | 0 Days | 132 Days |
Enterprise Value | $22.86B | $85.46B |
Dividend Yield | — | 0.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moody's Corporation (MCO) trades at $449.63, down 0.59% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth has accelerated from $5.5B in 2022 to $7.7B in 2025, while net income margins expanded to 34.25%. Recent developments include strategic partnerships and board appointments, supporting the company's market leadership in credit analytics.
The investment outlook is positive given Moody's robust profitability, high ROE of 80.15%, and analyst consensus price target of $536.40 (19% upside). Risks include high valuation multiples (P/E 28.53, P/S 9.79) and exposure to economic cycles affecting credit demand. Institutional sentiment remains bullish with 56% buy ratings, though technical indicators suggest near-term consolidation near support at $440.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →
